Pakistan received its first shipment of single-dose Chinese vaccine Convidecia, manufactured by CanSino Biologics Inc. 60,000 doses of the vaccine reached Islamabad on Tuesday, with National Health Services, Regulations and Coordination (NHSR&C) officially substantiating the shipment.
The National Command and Operation Centre has announced that the vaccine will be administered only to citizens above 80 years of age in order to eliminate the need for a second visit to vaccination centers.
“Owing to its availability in small quantity, it is recommended that it should only be administered in large cities with high number of COVID-19 cases,” NCOC officials stated.
Earlier this week, Asad Umar, chief of the National Command and Operation Centre, revealed that Pakistan will import the China’s CanSinoBio vaccine in bulk. From this shipment, 3 million doses of the vaccine will be created, the Minister stated.
“The bulk vaccine received will be formulated, sterilized and packed in Pakistan. For this purpose special equipment has been procured and manpower is being trained,” he stated in a tweet.
